ARCHIVES

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Cancer Incidence, Mortality Rates Trend Downward, NCI, ACS Say In “Report Card”

March 13, 1998

In Brief: Daniel Nixon Of Emory to Head Prevention Program; Henderson To Get Rosenthal Award

January 30, 1987

CALGB Grant OKed, But Group May Lose Support For Its Non-Hematologic Segments

January 8, 1982

Chronobiology Review Still Delayed

May 5, 1989

NCAB Subcommittee Approves Compromise On Changes In Organ Site Program

April 9, 1982

Community Based Organizing Nearly Complete; Conn. Still Planning

November 25, 1977